Discussion Post 13
On the following three weeks (13 to 15) we will be covering the APNP scope on practice: relationship with supervised physician via protocol covered on your portfolio assignment, new introduced controlled substance prescribed abilities, our role on research and evidence based practice, etcetera. It is very important to understand your scope of practice which basically determined yours legal scope of practice.
The scope of practicedescribes the procedures, actions, and processes that a health care practitioner is permitted to undertake in keeping with the terms of their professional license.
(Scope of practice – Wikipedia https://en.wikipedia.org/wiki/Scope of_practice)
1. Scope of practice of nurse practitioners: professional role. https://www.aanp.org/advocacy/advocacy-resource/position-statements/scope-of-practice-for-nurse-practitioners
2. State practice environment (AANP). https://www.aanp.org/advocacy/state/state-practice-environment
3. I want to take an opportunity to discuss our new granted privilege to prescribe controlled substance. There are five classes of substance considered under the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Comprehensive Drug Abuse Prevention and Control Act of 1970, 2019).This privilege was legally approved in Florida, the last state to grant such a privilege for midlevel practitioners, in 2017( Kellangs & Maye, 2017). Once licensed as Florida Nurse Practitioner (NP) license, you will need 2 hours of controlled substance prescription CEUs and to apply for the DEA license. The application cost $ 731 and it’s valid for three years. NPs are required to have a controlled substance agreement with the supervising physician.
DEA website https://apps.deadiversion.usdoj.gov/webforms/jsp/regapps/common/newAppLogin.jsp
Comprehensive Drug Abuse Prevention and Control Act of 1970. Retrieved on March 10, 2019 fromhttps://en.wikipedia.org/wiki/
Kellams, J. R., & Maye, J. P. (2017). The last state to grant nurse practitioners DEA licensure: An education improvement initiative on the Florida prescription drug monitoring program. Journal of addictions nursing, 28(3), 135-142. doi: 10.1097/JAN.0000000000000177
U.S Department of Justice and Drug Enforcement Administration. Diversion control division. Application for Registration Under Controlled Substances Act of 1970 (NewApplicants Only). Retrieved from https://apps.deadiversion.usdoj.gov/webforms/jsp/regapps/common/newAppLogin.jsp
On initial post remember to include your scholarly reference (EBP published within last 5 years). You can discuss the knowledge gained when reviewing the Family APRN scope of practice. Example: you can select to post about the new controlled substance privilege and requirements (CEU, DEA license, protocol with MD), eForce supervision, the advantages and its implication on our NP practices, etcetera.